Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Venousonics Ltd.

This article was originally published in Start Up

Executive Summary

Venousonics hopes to be the first company to launch a completely non-invasive technology for treating varicose veins, and eventually smaller veins as well. It is delivering highly-focused ultrasound through the skin to induce cavitation. The ensuing microbubbles explode and destroy the vein wall, resulting in vessel closure. The Israeli company aims to provide fast, effective and pain-free relief of venous reflux.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts